Characteristics of Patients Who Survived 2 Years After Surgery for Spinal Metastases: Can We Avoid Inappropriate Patient Selection?
- Verlaan, J.J.
- Choi, D.
- Versteeg, A.
- Albert, T.
- Arts, M.
- Balabaud, L.
- Bunger, C.
- Buchowski, J.M.
- Chung, C.K.
- Coppes, M.H.
- Crockard, H.A.
- Depreitere, B.
- Fehlings, M.G.
- Harrop, J.
- Kawahara, N.
- Kim, E.S.
- Lee, C.S.
- Leung, Y.
- Liu, Z.J.
- Martin-Benlloch, A.
- Massicotte, E.M.
- Mazel, C.
- Meyer, B.
- Peul, W.
- Quraishi, N.A.
- Tokuhashi, Y.
- Tomita, K.
- Ulbricht, C.
- Wang, M.
- Oner, F.C.
Publication date
September 2016
DOI Publisher
American Society of Clinical Oncology (ASCO)Abstract
Poor performance status at presentation is the strongest indicator of poor short-term survival, whereas low disease load and favorable tumor histology are associated with longer-term survival. (C) 2016 by American Society of Clinical Oncolog
Add to ORKG